# Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

> **NCT00935389** · NA · COMPLETED · sponsor: **Nanjing University School of Medicine** · enrollment: 44 (actual)

## Conditions studied

- Lupus Nephritis
- Proteinuria
- CTX

## Interventions

- **DRUG:** tripterygium glycosides

## Key facts

- **NCT ID:** NCT00935389
- **Lead sponsor:** Nanjing University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935389, "Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00935389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*